Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Transitional Cell × Injections × 30 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 16 Myelodysplastic Syndromes 6 Leukemia, Myelomonocytic, Chronic 5 Myeloproliferative Disorders 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Ovarian Neoplasms 2 Leukemia, Monocytic, Acute 2 Advanced Solid Tumour 2 Uterine Cervical Neoplasms 1 Thrombocythemia, Essential 1 Strabismus 1 Solid Tumor 1 Sarcoma 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Non-Squamous Non-small Cell Lung Cancer 1 Non-Muscle Invasive Bladder Neoplasms 1 Neoplasms 1 Myelodysplastic-Myeloproliferative Diseases 1 Multiple Sclerosis 1 Melanoma 1 Lymphoma, T-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Lung Neoplasms 1 Leukemia, Myelomonocytic, Acute 1 Leukemia, Biphenotypic, Acute 1 Leukemia, Basophilic, Acute 1 Idiopathic Pulmonary Fibrosis 1

Interventions

pembrolizumab 14 enfortumab vedotin 10 Specimen Handling 8 Magnetic Resonance Spectroscopy 8 Nivolumab 7 Carboplatin 5 avelumab 4 Ipilimumab 4 Cisplatin 4 Gemcitabine 3 Docetaxel 3 sacituzumab govitecan 2 cabozantinib 2 atezolizumab 2 Paclitaxel 2 CTLA-4 Antigen 2 Biopsy 2 zimberelimab 1 zanidatamab 1 tazemetostat 1 soluble LAG-3 protein, human 1 sargramostim 1 sapanisertib 1 relatlimab 1 regorafenib 1 lenvatinib 1 erdafitinib 1 durvalumab 1 dodecyl maltoside 1 darolutamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡